{
    "nctId": "NCT02762851",
    "officialTitle": "A Randomized Controlled Trial of Influenza Vaccine to Prevent Adverse Vascular Events",
    "inclusionCriteria": "* Age \u2265 18 years and NYHA (New York Heart Association) functional class II, III and IV\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Anaphylactic reaction to a previous dose of TIV(trivalent influenza vaccine)\n* Known IgE( Immunoglobulin E)-mediated hypersensitivity to eggs manifested as hives, swelling of the mouth and throat, difficulty in breathing, hypotension, or shock\n* Guillain-Barr\u00e9 syndrome within eight weeks of a previous influenza vaccine\n* Anaphylactic reaction to neomycin\n* Patients who have had influenza vaccine in two of the three previous years"
}